COVID: AstraZeneca admits vaccine shortfall for EU
February 25, 2021
The delivery shortfall is contributing to the bloc's slow vaccine rollout, lagging behind countries such as the UK and Israel. But another vaccine maker could get EU approval soon.
Pharmaceutical company AstraZeneca will deliver to the EU less than half the amount of COVID-19 vaccine doses that it pledged for the first quarter of 2021, company boss Pascal Soriot admitted to European lawmakers on Thursday.
The drugmaker has long said it will not be able to fulfill its target, but the confirmation remains a blow to the EU's vaccine rollout.
The bloc has fallen far behind the United States, Britain and Israel in vaccinating its public, blaming supply chain issues. About 8% of the adult population of the EU have been vaccinated, according to European Commission Chief Ursula von der Leyen.
AstraZeneca will now try and deliver 40 million doses of its COVID-19 vaccine by the end of March, down from an initial 90 million.
The pledge is in line with previous statements from the company.